stars 1 stars 2 stars 3

Morphochem Aktiengesellschaft für kombinatorische Chemie is a private clinical-stage pharmaceutical company located in Munich, Germany. Morphochem is a 100-percent subsidiary of Biovertis AG, headquartered in Vienna, Austria. Biovertis's major shareholder is TVM Capital Life Science.

Morphochem AG Questions

The Morphochem AG annual revenue was $9 million in 2026.

Peter Seufer-Wasserthal is the Vice President Business Development of Morphochem AG.

1 people are employed at Morphochem AG.

The NAICS codes for Morphochem AG are [32541, 325, 3254, 32].

The SIC codes for Morphochem AG are [28, 283, 2834].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users